发明名称 |
Oral pharmaceutical extended release dosage form |
摘要 |
An enteric coated pharmaceutical extended release dosage form of a H+, K+-ATPase inhibitor giving an extended plasma concentration profile of a H+, K+-ATPase inhibitor. The extended plasma profile is obtained by a pharmaceutical composition which comprises a core material of a hydrophilic or hydrophobic matrix, and the H+, K+-ATPase inhibitor and optionally pharmaceutically acceptable excipients. The dosage form may be administered once daily.
|
申请公布号 |
US6605303(B1) |
申请公布日期 |
2003.08.12 |
申请号 |
US20000555744 |
申请日期 |
2000.01.15 |
申请人 |
ASTRAZENECA AB |
发明人 |
KAREHILL PER-GUNNAR;LUNDBERG PER JOHAN |
分类号 |
C07D235/28;A61K9/20;A61K9/22;A61K9/26;A61K9/28;A61K9/52;A61K31/00;A61K31/4184;A61K31/4188;A61K31/44;A61K31/4427;A61K31/4439;A61K47/02;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61P1/04;C07D401/12;C07D413/14;C07D471/04;C07D495/04;(IPC1-7):A61K9/14;A61K9/16 |
主分类号 |
C07D235/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|